Product
BNT165b1
1 clinical trial
1 indication
Indication
MalariaClinical trial
An Exploratory Phase I, Randomized, Observer-blind, Placebo-controlled Dose Escalation Trial Evaluating the Safety, Tolerability and Immunogenicity of an Investigational RNA-based Vaccine for Active Immunization Against MalariaStatus: Active (not recruiting), Estimated PCD: 2024-02-23